arsenic trioxide has been researched along with Lymphoma, B-Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, A; Spitz, DR; Weiner, GJ | 1 |
| Giri, U; Kala, SV; Lieberman, MW; Story, MD; Terry, NH | 1 |
| Chen, L; Chen, SY; Li, QY; Xu, XP; Xu, XW; Yi, K; Zhou, F | 1 |
| Duan, Y; Li, HM; Liu, H; Yu, MJ; Zhang, XM | 1 |
| Au, WY; Fong, BM; Kwong, YL; Tam, S; Wan, TS; Yip, SF | 1 |
1 review(s) available for arsenic trioxide and Lymphoma, B-Cell
| Article | Year |
|---|---|
Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Combined Modality Therapy; Dexamethasone; Drug Resistance, Neoplasm; Humans; Lymphoma, B-Cell; Multiple Myeloma; Oxidation-Reduction; Oxidative Stress; Oxides; Pyrazines; Radiotherapy | 2012 |
4 other study(ies) available for arsenic trioxide and Lymphoma, B-Cell
| Article | Year |
|---|---|
Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Cell Survival; Cloning, Molecular; Drug Resistance, Neoplasm; Flow Cytometry; Glutathione; Glutathione Transferase; Humans; Lymphoma, B-Cell; Membrane Potentials; Mice; Mitochondria; Oxides | 2005 |
[Effects of dexamethasone on arsenic trioxide induced apoptosis, NF-kappaB activation and gene expression in lymphoma cell line].
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Dexamethasone; Drug Interactions; Glucocorticoids; Humans; Immunohistochemistry; Lymphoma, B-Cell; Matrix Metalloproteinase 9; NF-kappa B; Oxides; Vascular Endothelial Growth Factor A | 2005 |
[Inhibited proliferation of B-lymphoma Raji cells and down-regulated expression of VEGF by arsenic trioxide].
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Proliferation; Down-Regulation; Humans; Lymphoma, B-Cell; Oxides; RNA, Messenger; Vascular Endothelial Growth Factor A | 2006 |
Second hematological malignancies during arsenic trioxide therapy of B-cell lymphomas.
Topics: Aged; Arsenic Trioxide; Arsenicals; Female; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Male; Neoplasms, Second Primary; Oxides | 2009 |